1. Home
  2. ADAG vs ALAR Comparison

ADAG vs ALAR Comparison

Compare ADAG & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • ALAR
  • Stock Information
  • Founded
  • ADAG 2011
  • ALAR 2013
  • Country
  • ADAG China
  • ALAR Israel
  • Employees
  • ADAG N/A
  • ALAR N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • ALAR Computer Software: Prepackaged Software
  • Sector
  • ADAG Health Care
  • ALAR Technology
  • Exchange
  • ADAG Nasdaq
  • ALAR Nasdaq
  • Market Cap
  • ADAG 81.9M
  • ALAR 94.0M
  • IPO Year
  • ADAG 2021
  • ALAR 2018
  • Fundamental
  • Price
  • ADAG $1.82
  • ALAR $6.36
  • Analyst Decision
  • ADAG Strong Buy
  • ALAR Strong Buy
  • Analyst Count
  • ADAG 1
  • ALAR 1
  • Target Price
  • ADAG $8.00
  • ALAR $11.00
  • AVG Volume (30 Days)
  • ADAG 38.1K
  • ALAR 102.5K
  • Earning Date
  • ADAG 03-24-2025
  • ALAR 03-20-2025
  • Dividend Yield
  • ADAG N/A
  • ALAR N/A
  • EPS Growth
  • ADAG N/A
  • ALAR N/A
  • EPS
  • ADAG N/A
  • ALAR 0.08
  • Revenue
  • ADAG $103,204.00
  • ALAR $31,824,000.00
  • Revenue This Year
  • ADAG $6,488.89
  • ALAR $12.46
  • Revenue Next Year
  • ADAG $57.50
  • ALAR $26.00
  • P/E Ratio
  • ADAG N/A
  • ALAR $7.49
  • Revenue Growth
  • ADAG N/A
  • ALAR 20.00
  • 52 Week Low
  • ADAG $1.33
  • ALAR $5.84
  • 52 Week High
  • ADAG $3.58
  • ALAR $46.69
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 50.71
  • ALAR 38.82
  • Support Level
  • ADAG $1.39
  • ALAR $5.84
  • Resistance Level
  • ADAG $1.83
  • ALAR $7.72
  • Average True Range (ATR)
  • ADAG 0.18
  • ALAR 0.51
  • MACD
  • ADAG -0.02
  • ALAR -0.02
  • Stochastic Oscillator
  • ADAG 72.59
  • ALAR 20.00

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.

Share on Social Networks: